|
Index of reports
> Cases with Injection Site Pain (58)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sandostatin (Octreotide) where reactions include injection site pain. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 58 Next >>
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: male
Reactions: Abdominal Pain, Productive Cough, Pruritus, Nasopharyngitis, Metastases To Liver, Pyrexia, Faecal Volume Increased, Hot Flush, Fatigue, Cough, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Gastrointestinal Neoplasm, Diarrhoea, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Other drugs received by patient: Antibiotics; Morphine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-23
Patient: female, weighing 49.4 kg (108.8 pounds)
Reactions: Weight Decreased, Rectal Haemorrhage, Pain, Oral Discomfort, Injection Site Erythema, Lymph Node Pain, Anorectal Discomfort, Abdominal Distension, Dizziness, Cough, Nervousness, Injection Site Mass, Back Pain, Nausea, Haemorrhoids, Injection Site Pain, Hypoaesthesia, Diarrhoea, Alopecia, Pollakiuria, Blood Pressure Decreased, Depressed Mood, Frustration, DRY Eye, Asthenia
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Thyroid Cancer
Start date: 2004-07-13
End date: 2007-03-06
Sandostatin
Dosage: 50 ug, unk
Indication: Thyroid Cancer
Sandostatin
Dosage: 100 ug, bid
End date: 2012-02-23
Sandostatin LAR
Dosage: 30 mg every 3 weeks
End date: 2007-03-06
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-14
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Blood Pressure Systolic Increased, Suffocation Feeling, Wheezing, Rhinorrhoea, Injection Site Pain, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Cough, Blood Pressure Diastolic Decreased, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2011-07-15
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Other drugs received by patient: Dicyclomine; Bisoprolol; Metoprolol
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-03
Patient: male
Reactions: Abdominal Pain, Nasopharyngitis, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Diarrhoea, Gastrointestinal Neoplasm, Neoplasm Malignant, Dysphonia, Arthralgia, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Morphine Sulfate
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-08-01
Patient: female
Reactions: Haemorrhage, Rectal Haemorrhage, Malaise, Fatigue, White Blood Cell Count Increased, Lethargy, Vomiting, Loss of Control of Legs, Nausea, Urinary Tract Infection, Injection Site Pain, Facial Pain, Blood Creatine Increased, Tremor, Discomfort, Haemoglobin Decreased, Diarrhoea, Liver Abscess, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Carcinoid Tumour
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Start date: 2011-07-05
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Carcinoid Tumour
Start date: 2011-07-05
Other drugs received by patient: Norfloxacin
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-07-25
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Confusional State, Weight Decreased, Incorrect Route of Drug Administration, Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Discomfort, Injection Site Erythema, Malaise, Fatigue, Hot Flush, Oedema Peripheral, Dizziness, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2012-05-04
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 0.75 ml, tid prn
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-07-18
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Suffocation Feeling, Blood Pressure Systolic Increased, Wheezing, Rhinorrhoea, Injection Site Pain, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Blood Pressure Diastolic Decreased, Cough, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Other drugs received by patient: Bisoprolol Fumarate; Metoprolol Succinate; Dicyclomine
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-07-17
Patient: male
Reactions: Hepatic Neoplasm Malignant, Injection Site Pain
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2012-01-26
Sandostatin
Dosage: 50 ug, unk
Indication: Neuroendocrine Tumour
Start date: 2012-01-19
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-11
Patient: female, weighing 49.4 kg (108.8 pounds)
Reactions: Weight Decreased, Rectal Haemorrhage, Pain, Oral Discomfort, Injection Site Erythema, Lymph Node Pain, Anorectal Discomfort, Abdominal Distension, Dizziness, Nervousness, Cough, Injection Site Mass, Nausea, Haemorrhoids, Injection Site Pain, Hypoaesthesia, Diarrhoea, Alopecia, Pollakiuria, Blood Pressure Decreased, Frustration, DRY Eye, Depressed Mood, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Thyroid Cancer
Sandostatin LAR
Dosage: 30 mg every 3 weeks
End date: 2007-03-06
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Thyroid Cancer
Start date: 2004-07-13
End date: 2007-03-06
Sandostatin
Dosage: 100 ug, bid
End date: 2012-02-23
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-06-06
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Confusional State, Weight Decreased, Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Erythema, Fatigue, Injection Site Discomfort, Malaise, Hot Flush, Oedema Peripheral, Dizziness, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Blood Pressure Systolic Increased, Pain in Extremity, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2012-05-04
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, qmo
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-06-01
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Neoplasm Malignant, Dysphonia, Gastrointestinal Neoplasm, Diarrhoea, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Other drugs received by patient: Morphine
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-05-29
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Suffocation Feeling, Blood Pressure Systolic Increased, Wheezing, Injection Site Pain, Rhinorrhoea, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Blood Pressure Diastolic Decreased, Cough, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Other drugs received by patient: Dicyclomine; Bisoprolol Fumarate
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-28
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Confusional State, Weight Decreased, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Fatigue, Injection Site Discomfort, Injection Site Erythema, Malaise, Hot Flush, Oedema Peripheral, Abdominal Distension, Dizziness, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin
Dosage: 0.75 ml, bid
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-25
Patient: female
Reactions: Back Pain, Blood Pressure Increased, Abdominal Pain, Renal Disorder, Pain, Breakthrough Pain, Injection Site Pain, Laceration, Neoplasm Progression, Fall, Dysgeusia, Malaise, Spinal Compression Fracture, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every four weeks
End date: 2012-02-22
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-20
End date: 2011-01-23
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-24
Other drugs received by patient: Fentanyl-100; Dexamethasone; Dilaudid
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-22
Patient: female
Reactions: Blood Pressure Increased, Back Pain, Abdominal Pain, Renal Disorder, Pain, Injection Site Pain, Laceration, Breakthrough Pain, Fall, Dysgeusia, Malaise, Spinal Compression Fracture, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-24
Sandostatin
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-20
End date: 2011-01-23
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin LAR
Dosage: 20 mg, every four weeks
Other drugs received by patient: Dexamethasone; Dilaudid; Fentanyl-100
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-18
Patient: female
Reactions: Abdominal Pain, Metastases To Liver, Injection Site Haematoma, Pain, Neoplasm Progression, Blood Calcium Increased, Injection Site Swelling, Stasis Dermatitis, Constipation, Erythema, Malaise, Injection Site Erythema, Injection Site Induration, Oedema Peripheral, Abdominal Distension, Injection Site Mass, Injection Site Pain, Skin Plaque, Blood Parathyroid Hormone Increased, Flushing, Neoplasm Malignant, Joint Swelling, Alopecia
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 60 mg, every 4 weeks
Sandostatin LAR
Dosage: 40 mg, every four weeks
Indication: Neuroendocrine Tumour
Start date: 2010-12-20
Sandostatin
Dosage: 1 ml, tid
Indication: Neuroendocrine Tumour
Start date: 2010-04-01
Sandostatin
Dosage: 1.5 ml, tid
Other drugs received by patient: Fragmin
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-09
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Weight Decreased, Confusional State, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Hot Flush, Malaise, Injection Site Erythema, Fatigue, Oedema Peripheral, Abdominal Distension, Dizziness, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-05-09
Patient: male
Reactions: Weight Decreased, Abdominal Pain, Nasopharyngitis, Mouth Ulceration, Skin Burning Sensation, Oropharyngeal Pain, Erythema, Gastritis, Haematemesis, Abdominal Discomfort, Hot Flush, Fatigue, Injection Site Induration, Decreased Appetite, Cough, Injection Site Mass, Vomiting, Stomatitis, Nausea, Injection Site Pain, Diarrhoea, Hypophagia, Rash Maculo-Papular, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every three weeks
End date: 2011-06-08
Sandostatin
Dosage: 500 ug, bid
Start date: 2011-08-25
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 40 mg every three weeks
End date: 2011-05-21
Sandostatin
Dosage: 150 ug, bid
Start date: 2011-02-14
End date: 2011-02-17
Sandostatin
Dosage: 250 ug, bid
Start date: 2011-06-08
Sandostatin
Dosage: 500 ug, bid
Start date: 2011-08-25
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2009-09-10
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 40 mg, qmo
Sandostatin
Dosage: 100 ug, tid
Indication: Neuroendocrine Tumour
Start date: 2011-02-01
End date: 2011-02-14
Sandostatin
Dosage: 500 ug, tid
Other drugs received by patient: Mesalamine; Insulin; Aspirin; Gravol TAB; Fragmin; Pantoprazole Sodium
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-08
Patient: female, weighing 49.4 kg (108.8 pounds)
Reactions: Weight Decreased, Rectal Haemorrhage, Pain, Oral Discomfort, Injection Site Erythema, Lymph Node Pain, Anorectal Discomfort, Abdominal Distension, Dizziness, Cough, Nervousness, Injection Site Mass, Nausea, Haemorrhoids, Injection Site Pain, Hypoaesthesia, Diarrhoea, Alopecia, Pollakiuria, Asthenia, Depressed Mood, DRY Eye, Frustration, Blood Pressure Decreased
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Thyroid Cancer
Sandostatin LAR
Dosage: 30 mg every 3 weeks
End date: 2007-03-06
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Thyroid Cancer
Start date: 2004-07-13
End date: 2007-03-06
Sandostatin
Dosage: 100 ug, bid
End date: 2012-02-23
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-04-27
Patient: female
Reactions: Abdominal Pain, Metastases To Liver, Injection Site Haematoma, Pain, Blood Calcium Increased, Neoplasm Progression, Injection Site Swelling, Constipation, Erythema, Malaise, Injection Site Erythema, Injection Site Induration, Abdominal Distension, Injection Site Mass, Injection Site Pain, Blood Parathyroid Hormone Increased, Flushing, Neoplasm Malignant, Alopecia
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every four weeks
Indication: Neuroendocrine Tumour
Start date: 2010-12-20
Sandostatin
Dosage: 1 ml, tid
Indication: Neuroendocrine Tumour
Start date: 2010-04-01
Sandostatin LAR
Dosage: 60 mg, every 4 weeks
Sandostatin
Dosage: 1.5 ml, tid
Other drugs received by patient: Fragmin
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-04-20
Patient: female
Reactions: Abdominal Pain, Metastases To Liver, Pain, Neoplasm Progression, Blood Calcium Increased, Injection Site Swelling, Constipation, Erythema, Injection Site Erythema, Malaise, Injection Site Induration, Abdominal Distension, Injection Site Mass, Injection Site Pain, Blood Parathyroid Hormone Increased, Flushing, Neoplasm Malignant, Alopecia
Drug(s) suspected as cause:
Sandostatin
Dosage: 1.5 ml, tid
Sandostatin LAR
Dosage: 40 mg, every four weeks
Indication: Neuroendocrine Tumour
Start date: 2010-12-20
Sandostatin
Dosage: 1 ml, tid
Indication: Neuroendocrine Tumour
Start date: 2010-04-01
Sandostatin LAR
Dosage: 60 mg, every 4 weeks
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-04-13
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Weight Decreased, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Erythema, Hot Flush, Malaise, Fatigue, Oedema Peripheral, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Vertigo
Drug(s) suspected as cause:
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, qmo
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-06
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Hot Flush, Fatigue, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Gastrointestinal Neoplasm, Dysphonia, Neoplasm Malignant, Arthralgia, Diarrhoea, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Other drugs received by patient: Morphine
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-04-05
Patient: female
Reactions: Abdominal Pain, Pedal Pulse Abnormal, Loss of Consciousness, Malaise, Psychiatric Symptom, Epistaxis, Back Pain, Visual Field Defect, Pain in Extremity, Anaemia, Hypotension, General Physical Health Deterioration, Stress, Abdominal Pain Upper, Speech Disorder, Myalgia, Fatigue, Transient Ischaemic Attack, Blood Sodium Decreased, Blood Pressure Increased, Vomiting, Nausea, Muscular Weakness, Injection Site Pain, Cerebrovascular Accident, Diarrhoea, Arthralgia, Hypophagia, Memory Impairment, Gait Disturbance, Asthenia, Feeling Abnormal, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, every 3 weeks
Start date: 2010-06-02
Sandostatin
Dosage: 20 mg, bid
Sandostatin LAR
Dosage: 20 mg, qmo
End date: 2011-04-05
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2007-08-24
End date: 2011-04-05
Sandostatin
Indication: Neuroendocrine Tumour
Other drugs received by patient: Ferrous Sulfate TAB; Calcium with Vitamin D; Swine FLU Vaccine, Monovalent; Asaphen; Novo-Venlafaxine; Metformin HCL; Novo-Loperamide; Cyproheptadine HCL; Senntab; Novo-Pantoprazole; Novo-Docusate; Synthroid; Oxazepam
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-04-02
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Suffocation Feeling, Blood Pressure Systolic Increased, Wheezing, Injection Site Pain, Rhinorrhoea, Diarrhoea, Crepitations, Bradycardia, Bronchitis, Asthenia, Cough, Blood Pressure Diastolic Decreased, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Other drugs received by patient: Bisoprolol Fumarate; Dicyclomine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-03-29
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Diarrhoea, Gastrointestinal Neoplasm, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Morphine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-03-19
Patient: female
Reactions: Blood Pressure Increased, Back Pain, Abdominal Pain, Renal Disorder, Pain, Laceration, Injection Site Pain, Breakthrough Pain, Fall, Dysgeusia, Spinal Compression Fracture, Malaise, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-20
End date: 2011-01-23
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Metastatic Carcinoid Tumour
Start date: 2011-01-24
Sandostatin LAR
Dosage: 20 mg, qmo
Sandostatin LAR
Dosage: 20 mg, every four weeks
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Other drugs received by patient: Dexamethasone; Fentanyl; Dilaudid
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-03-16
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Hot Flush, Fatigue, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Neoplasm Malignant, Diarrhoea, Arthralgia, Dysphonia, Gastrointestinal Neoplasm, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Other drugs received by patient: Morphine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-03-07
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Blood Pressure Systolic Increased, Suffocation Feeling, Wheezing, Rhinorrhoea, Injection Site Pain, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Blood Pressure Diastolic Decreased, Cough, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Other drugs received by patient: Bisoprolol Fumarate; Dicyclomine
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-03-06
Patient: female, weighing 49.4 kg (108.8 pounds)
Reactions: Weight Decreased, Pain, Rectal Haemorrhage, Oral Discomfort, Injection Site Erythema, Lymph Node Pain, Anorectal Discomfort, Dizziness, Abdominal Distension, Nervousness, Cough, Injection Site Mass, Nausea, Haemorrhoids, Injection Site Pain, Hypoaesthesia, Diarrhoea, Alopecia, Pollakiuria, Blood Pressure Decreased, Asthenia, Depressed Mood, DRY Eye, Frustration
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Thyroid Cancer
Start date: 2004-07-13
End date: 2007-03-06
Sandostatin
Dosage: 50 ug, unk
Indication: Thyroid Cancer
Sandostatin LAR
Dosage: 30 mg every 3 weeks
End date: 2007-03-06
Sandostatin
Dosage: 100 ug, bid
End date: 2012-02-23
Page 1 Next >>
|
